UNH Stock Jumps 7% Pre-Market: Margin Story Drives Rally  – Retail Expects Over 40% Upside

The company also announced plans to repurchase at least $2 billion worth of its shares by the end of the second quarter.
In this photo illustration, a smartphone displays the logo of UnitedHealth Group Incorporated. (Photo illustration by Cheng Xin/Getty Images)
In this photo illustration, a smartphone displays the logo of UnitedHealth Group Incorporated. (Photo illustration by Cheng Xin/Getty Images)
Profile Image
Arnab Paul·Stocktwits
Published Apr 21, 2026   |   7:48 AM EDT
Share
·
Add us onAdd us on Google
Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...
  • UnitedHealth raised its FY2026 adjusted earnings guidance to more than $18.25 per share from $17.75 per share.
  • The company’s medical cost ratio was 83.9% for Q1, down 90 basis points from last year.
  • The insurer’s Q1 adjusted net earnings of $7.23 per share were well above the consensus estimates of $6.61 per share.

Advertisement|Remove ads.

UnitedHealth Group Inc. (UNH) shares gained more than 7% in pre-market trading on Tuesday after a strong quarter, but more importantly, its outlook shift and improved margin signals caught investors' attention. The insurer raised its full-year 2026 earnings outlook and announced a $2 billion share buyback.

UnitedHealth raised its FY2026 adjusted earnings guidance to more than $18.25 per share. It had previously guided for earnings of $17.75 per share. This is above Wall Street’s estimates of $17.87 per share, according to Fiscal.ai.

Read Next
Loading...
Loading...

The company also announced plans to repurchase at least $2 billion worth of its shares by the end of the second quarter (Q2) under its existing buyback program.

Advertisement|Remove ads.

Better-Than-Expected Q1 Print

UnitedHealth Group’s first quarter (Q1) revenues came in 1.9% higher at $111.7 billion, beating Street estimates. The insurer’s Q1 adjusted net earnings of $7.23 per share were well above the consensus estimates of $6.61 per share.

UnitedHealth Group’s medical cost ratio (MCR) was 83.9% for Q1, down 90 basis points from last year. The MCR improved by 20 basis points due to a previously disclosed reserve related to loss-making Optum Health contracts, the company said. The MCR represents the share of revenue spent on medical claims; a higher ratio indicates that costs are rising faster than revenue.

The company said Q1 operating margin increased to 6.6% from 6.% a year earlier, primarily driven by pricing adjustments across all business segments to offset elevated cost trends seen in the insurance space.

Advertisement|Remove ads.

UnitedHealth also mentioned that its acquisition of Alegeus Technologies to expand its consumer-focused healthcare solutions is expected to close in late 2026.

How Did Retail Traders React?

Retail sentiment on Stocktwits for UNH flipped to ‘extremely bullish’ from ‘neutral’ a day earlier, amid ‘high’ message volumes. UNH was also among the top trending tickers at the time of writing.

One user expects the stock to climb to $500 by the end of the year.

Advertisement|Remove ads.

Another user expects a multi-day run on the back of the Q1 results.

Advertisement|Remove ads.

Earlier this month, Morgan Stanley named UnitedHealth as ‘Top Pick’, adding that it “is not necessarily a call on the quarter, but a call on what should be a string of clean quarters that should drive incremental enthusiasm.”

Meanwhile, Jefferies raised its price target to $373 from $340 and maintained a ‘Buy’ rating, according to The Fly.

UNH stock has shed around 2% so far this year.

Advertisement|Remove ads.

For updates and corrections, email newsroom[at]stocktwits[dot]com.

Comments
Share your thoughts...

Comments posted here will also appear on symbol pages.

Follow on Google News
Read about our editorial guidelines and ethics policy

Advertisement|Remove ads.